SEARCH RESULTS

281838 RESULTS

Rob Williams


The University of Melbourne
Parkville, Australia

Verdiperstat

THERAPEUTICS 1-(2-Isopropoxyethyl)-2-thioxo-1,2,3,5-tetrahydro-pyrrolo[3,2-d]pyrimidin-4-one AstraZeneca Biohaven Pharmaceuticals AZD3241 BHV-3241 Small Molecule Inflammation Other Between 2008 and 2013, AstraZeneca completed multiple Phase 1 studies of AZD3241 ...

Levodopa

THERAPEUTICS AbbVie Acorda Therapeutics, Inc. Amneal Pharmaceuticals, Inc. L-Dopa, Sinemet Duodopa, Duopa Inbrija Parcopa Prolopa Rytary Stalevo Foslevodopa Small Molecule Other Neurotransmitters In 1975, the U.S. FDA approved the levodopa/carbidopa LD/CD pill, sold ...

Safinamide

THERAPEUTICS N2-{4-[(3-fluorobenzyl)oxy]benzyl}-L-alaninamide Newron Zambon Company S.p.A. Xadago Onstryv Small Molecule Other Neurotransmitters Between 2007 and 2012, two pivotal Phase 3 trials evaluated the efficacy of safinamide to reduce periods of fluctuating ...

MSK-DA01

THERAPEUTICS Bayer BlueRock Therapeutics Other Other Neurotransmitters Other In May 2021, BlueRock Therapeutics, a subsidiary of Bayer, began a Phase 1 safety study. Ten people who have had Parkinson’s disease for five to 15 years, and still respond to levodopa, will ...

Current Filters

  • Date Range : All x

Remove all filters

Filter By

DATE RANGE
  • All
  • Past 7 Days
  • Past 30 Days
  • Past 90 Days
  • Past 12 Months
  • Specific Dates
    1. From
      To

TYPE